Higher immune responses were elicited by mRNA-1083 than high-dose quadrivalent inactivated influenza vaccine for all 4 influenza strains and high-dose quadrivalent inactivated influenza vaccine for 3 ...
Research reveals a sharp decline in both the effectiveness and duration of protection from prior infection post-Omicron, underscoring the need for updated vaccines to sustain immunity Study: ...
mRNA-1083 induced higher immune responses than recommended standard-care influenza and COVID-19 vaccines. (HealthDay News) — mRNA-1083 vaccine is noninferior and induces higher immune responses than ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results